160 related articles for article (PubMed ID: 33131455)
1. Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study.
Liu J; Wang L; Hou Y; Zhao Y; Dou Z; Ma Y; Zhang D; Wu Y; Zhao D; Liu Z; Zhang F; Jin L; Zhang JY; Xu R; Shi M; Huang L; Wu Z; Han M; Gao GF; Wang FS
Emerg Microbes Infect; 2020 Dec; 9(1):2550-2561. PubMed ID: 33131455
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
[TBL] [Abstract][Full Text] [Related]
3. Combining CD4 recovery and CD4: CD8 ratio restoration as an indicator for evaluating the outcome of continued antiretroviral therapy: an observational cohort study.
Lee SS; Wong NS; Wong BCK; Wong KH; Chan KCW
BMJ Open; 2017 Sep; 7(9):e016886. PubMed ID: 28918411
[TBL] [Abstract][Full Text] [Related]
4. The predictive role of CD4
Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
[TBL] [Abstract][Full Text] [Related]
5. HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ART.
Zhang LX; Jiao YM; Zhang C; Song JW; Fan X; Xu RN; Huang HH; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS
Front Immunol; 2020; 11():1541. PubMed ID: 32793212
[No Abstract] [Full Text] [Related]
6. Immune restoration affects 10-year survival in people living with HIV/AIDS.
Aksak-Wąs BJ; Kowalska JD; Ząbek P; Serwin K; Rafalska-Kosior M; Gołąb J; Chober D; Skonieczna-Żydecka K; Hackiewicz M; Parczewski M
HIV Med; 2023 Mar; 24(3):325-334. PubMed ID: 36054430
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
[TBL] [Abstract][Full Text] [Related]
8. Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.
Gras L; May M; Ryder LP; Trickey A; Helleberg M; Obel N; Thiebaut R; Guest J; Gill J; Crane H; Dias Lima V; dʼArminio Monforte A; Sterling TR; Miro J; Moreno S; Stephan C; Smith C; Tate J; Shepherd L; Saag M; Rieger A; Gillor D; Cavassini M; Montero M; Ingle SM; Reiss P; Costagliola D; Wit FWNM; Sterne J; de Wolf F; Geskus R;
J Acquir Immune Defic Syndr; 2019 Mar; 80(3):292-300. PubMed ID: 30531492
[TBL] [Abstract][Full Text] [Related]
9. Demographic and clinical factors associated with immune reconstitution in HIV/HBV co-infected and HIV mono-infected patients: a retrospective cohort study.
Jiang TY; Hou JH; Su B; Zhang T; Yang Y; Liu ZY; Wang W; Guo CP; Dai LL; Sun LJ; Wu H
HIV Med; 2020 Dec; 21(11):722-728. PubMed ID: 33369028
[TBL] [Abstract][Full Text] [Related]
10. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy.
Kaufmann GR; Bloch M; Finlayson R; Zaunders J; Smith D; Cooper DA
AIDS; 2002 Feb; 16(3):359-67. PubMed ID: 11834947
[TBL] [Abstract][Full Text] [Related]
11. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study.
Serrano-Villar S; Martínez-Sanz J; Ron R; Talavera-Rodríguez A; Fernández-Felix BM; Herrera S; Muriel A; Fanjul F; Portilla J; Muñoz J; Amador C; de Zárraga MA; Vivancos MJ; Moreno S;
Lancet HIV; 2020 Aug; 7(8):e565-e573. PubMed ID: 32763219
[TBL] [Abstract][Full Text] [Related]
12. Incomplete Recovery of CD4 Cell Count, CD4 Percentage, and CD4/CD8 Ratio in Patients With Human Immunodeficiency Virus Infection and Suppressed Viremia During Long-term Antiretroviral Therapy.
Mutoh Y; Nishijima T; Inaba Y; Tanaka N; Kikuchi Y; Gatanaga H; Oka S
Clin Infect Dis; 2018 Aug; 67(6):927-933. PubMed ID: 29509894
[TBL] [Abstract][Full Text] [Related]
13. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy.
Ndumbi P; Gillis J; Raboud J; Cooper C; Hogg RS; Montaner JS; Burchell AN; Loutfy MR; Machouf N; Klein MB; Tsoukas C;
HIV Med; 2014 Mar; 15(3):153-64. PubMed ID: 24304582
[TBL] [Abstract][Full Text] [Related]
15. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
[TBL] [Abstract][Full Text] [Related]
16. Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection.
Thornhill J; Inshaw J; Kaleebu P; Cooper D; Ramjee G; Schechter M; Tambussi G; Fox J; Samuel M; Miro JM; Weber J; Porter K; Fidler S
J Acquir Immune Defic Syndr; 2016 Sep; 73(1):69-73. PubMed ID: 27070122
[TBL] [Abstract][Full Text] [Related]
17. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
[TBL] [Abstract][Full Text] [Related]
18. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study.
Mussini C; Lorenzini P; Cozzi-Lepri A; Lapadula G; Marchetti G; Nicastri E; Cingolani A; Lichtner M; Antinori A; Gori A; d'Arminio Monforte A;
Lancet HIV; 2015 Mar; 2(3):e98-106. PubMed ID: 26424550
[TBL] [Abstract][Full Text] [Related]
19. Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment.
Landay A; da Silva BA; King MS; Albrecht M; Benson C; Eron J; Glesby M; Gulick R; Hicks C; Kessler H; Murphy R; Thompson M; White AC; Wolfe P; McMillan FI; Hanna GJ
Clin Infect Dis; 2007 Mar; 44(5):749-54. PubMed ID: 17278071
[TBL] [Abstract][Full Text] [Related]
20. CD4+/CD8+ ratio restoration in long-term treated HIV-1-infected individuals.
Caby F;
AIDS; 2017 Jul; 31(12):1685-1695. PubMed ID: 28700392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
